DIN 02442213 — SUFENTANIL CITRATE INJECTION USP 50 MCG
SUFENTANIL CITRATE INJECTION USP is a solution of Sufentanil marketed by STERIMAX INC. The full Sufentanil monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02442213
- Brand name
- SUFENTANIL CITRATE INJECTION USP
- Active ingredient
- Sufentanil
- Strength
- 50 MCG
- Dosage form
- SOLUTION
- Route
- EPIDURAL; INTRAVENOUS
- Manufacturer
- STERIMAX INC
- Health Canada status
- MARKETED
- Drug class
- Opioid analgesic (anesthesia adjunct)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Sufentanil products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02244147 | SUFENTANIL CITRATE INJECTION USP | 50 MCG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |